Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study

Oseltamivir Improved Thrombocytopenia During Veno-Arterial Extracorporeal Membrane Oxygenation in Adults With Refractory Cardiac Failure: A Single-Center Retrospective Real-World Study

Background: Severe thrombocytopenia is a common complication of extracorporeal membrane oxygenation (ECMO). Oseltamivir can be used to treat infection-associated thrombocytopenia.Objective: To evaluate the effect of oseltamivir on attenuating severe thrombocytopenia during ECMO.Methods: This was a s...

Full description

Bibliographic Details
Main Authors: Yuan Li, Lin Wang, Jianning Zhang, Hui Han, Han Liu, Chaoyang Li, Haipeng Guo, Yuguo Chen, Xiaomei Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
extracorporeal membrane oxygenation
veno-arterial
thrombocytopenia
platelets
cardiac failure
oseltamivir
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.645867/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.645867/full

Similar Items